Nexentis Technologies (NXTS) Income from Discontinued Operations (2024 - 2025)
Nexentis Technologies (NXTS) posted Income from Discontinued Operations of -$605000.0 for Q4 2025, down 297.71% on a QoQ basis from $306000.0 in Q3 2025, and up 22.04% year-over-year from -$495755.0 in Q4 2024.
Powered by 
Analysis
Nexentis Technologies (NXTS) Income from Discontinued Operations (2024 - 2025) Analysis & Trends
Nexentis Technologies has reported Income from Discontinued Operations for 2 years, with the latest figure at -$605000.0 in Q4 2025.
- On a quarterly basis, Income from Discontinued Operations rose 22.04% year-over-year to -$605000.0 in Q4 2025; TTM through Dec 2025 was -$1.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$561000.0, up 45.43% from the prior year.
- Income from Discontinued Operations was -$605000.0 for Q4 2025 at Nexentis Technologies, down from $306000.0 in the prior quarter.
- The five-year high for Income from Discontinued Operations was $306000.0 in Q3 2025, with the low at -$776000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | - |
| 10 | Nexentis Technologies | 1.40 Mn | -7.60 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -605,000.00 |
| Sep 30, 2025 | 306,000.00 |
| Jun 30, 2025 | -121,000.00 |
| Dec 31, 2024 | -776,000.00 |
| Sep 30, 2024 | -114,000.00 |
| Jun 30, 2024 | -21,000.00 |